Table 2. Adjusted U.S. National Estimates of Burden and Incidence of CDI, 2011.
Demographic Characteristic | Community-Associated CDI* | Health Care–Associated CDI† | All CDI | |||
---|---|---|---|---|---|---|
Estimated No. of Cases | Incidence per 100,000 Persons | Estimated No. of Cases | Incidence per 100,000 Persons | Estimated No. of Cases | Incidence per 100,000 Persons | |
All cases | 159,700 (132,900–186,000) | 51.9 (43.2–60.5) | 293,300 (264,200–322,500) | 95.3 (85.9–104.8) | 453,000 (397,100–508,500) | 147.2 (129.1–165.3) |
Sex | ||||||
Male | 64,300 (52,800–75,300) | 42.5 (34.8–49.8) | 132,700 (118,700–146,700) | 87.7 (78.5–97.0) | 197,000 (171,500–222,000) | 130.2 (113.3–146.8) |
Female | 95,400 (80,100–110,700) | 61.0 (51.2–70.8) | 160,600 (145,500–175,800) | 102.7 (93.1–112.5) | 256,000 (225,600–286,500) | 163.8 (144.3–183.3) |
Age group | ||||||
1–17 yr | 12,500 (10,000–15,000) | 17.9 (14.1–21.4) | 4400 (3200–5800) | 6.3 (4.6–8.3) | 16,900 (13,200–20,800) | 24.2 (18.7–29.7) |
18–44 yr | 35,600 (26,000–39,200) | 28.7 (22.9–34.5) | 20,800 (16,700–24,800) | 18.3 (14.7–21.9) | 53,400 (42,700–64,000) | 47.0 (37.6–56.4) |
45–64 yr | 54,100 (45,600–62,600) | 65.4 (55.1–75.6) | 68,800 (61,000–76,600) | 83.1 (73.7–92.5) | 122,900 (106,600–139,200) | 148.5 (128.8–168.1) |
≥65 yr | 60,500 (51,300–69,200) | 146.2 (124.0–167.2) | 193,300 (183,300–215,300) | 481.5 (442.8–520.1) | 259,800 (234,600–284,500) | 627.7 (566.8–687.3) |
Race‡ | ||||||
White | 138,100 (118,500–157,700) | 57.4 (49.2–65.5) | 259,900 (230,100–273,800) | 104.7 (95.6–113.8) | 390,000 (348,600–431,500) | 162.1 (144.8–179.3) |
Nonwhite | 21,600 (14,400–28,300) | 32.2 (21.5–42.2) | 41,400 (34,100–48,700) | 61.8 (50.9–72.7) | 63,000 (48,500–77,000) | 94.0 (72.4–114.9) |
Data for community-associated Clostridium difficile infection (CDI) were adjusted for age, sex, race, and a rate of use of nucleic acid amplification test (NAAT) of 52%. Ranges in parentheses are 95% confidence intervals.
Data for health care–associated CDI were adjusted for age, inpatient days, and a rate of use of NAAT of 52%.
Race was imputed for 18.7% of the observed cases of C. difficile infection.